Tags: chief commercial officersprofitable lifecyclepharmaceutical industryBispecific AntibodiesDLBCL
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Kristina Monllos Digiday Senior marketing editor at Digiday. Rhode Islander. St. Louis | Marketing Briefing: What recent earnings for P&G, Unilever and Coke say about where the industry is headed - 11 days ago | |
| 2 | Chris Clow HousingWire Editor at @rmdaily Seattle, Washington | Key reverse mortgage metrics saw an uptick in October even as business remains lukewarm - 11 days ago Here are the top 10 reverse mortgage securities issuers for 2023 - 10 months ago | |
| 3 | Daniel Cassady Artnews Reporter for ARTnews. Downtown | ||
| 4 | Kimeko McCoy Digiday Not actually funny. Marketing Award Winner. Senior Marketing Reporter. Co-host Digiday Podcast. Atlanta, Georgia | ||
| 5 | Scharon Harding Ars Technica Original tech news.
Expert advice.
Analysis of tech trends. NYC - Boston - Chicago - SF | ||
| 6 | Tim Schneider The Art Newspaper Art market editor. Near a keyboard | As the art market gears up for a season of global change, what are the odds of an autumn bounceback? - about 1 month ago Big ticket sales at Art Basel mask a nuanced market moment - 5 months ago The Gray Market: Why Sotheby’s $700m art-backed debt security is an acid test for the trade’s intentions - 6 months ago | |
| 7 | Connie Loizos TechCrunch Editor-in-chief, TechCrunch. San Francisco, California | Insight Partners is closing in on a whopping $10B+ new fund - 2 months ago | |
| 8 | Brooklee Han HousingWire Freelance writer. Boston, Massachusetts | ||
| 9 | Lillian Dickerson Inman Real estate news source. | ||
| 10 | Lars Mucklejohn City A.M. Banking reporter at CityAM. Contact via email. London |